Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -30.792% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1ccc(-c2cc(C(=O)NCCCN3CCOCC3)no2)cc1
b.) O=C(c1ccc([N+](=O)[O-])cc1)N1C=CC(C(F)(F)F)=NCC1
Answer: a. Cc1ccc(-c2cc(C(=O)NCCCN3CCOCC3)no2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2cc(C(=O)NCCCN3CCOCC3)no2)cc1
Cc1ccc(-c2cc(C(=O)NCCCN3CCOCC3)no2)cc1
5-(4-methylphenyl)-N-(3-morpholin-4-ylpropyl)-1,2-oxazole-3-carboxamide